 |
|
|
| |
Safety and Efficacy of 10mg (high-dose) bulevirtide (Myrcludex B) in combination with PEG-IFNa or TDF in patients with chronic HBV/HDV co-infection:
interim results.
|
| |
| |
AASLD 2019 Nov 8-11 Boston
Heiner Wedemeyer,
Katrin Schoneweis, Pavel Bogomolov, Natalia Voronkova, Vladimir Chulanov, Tatyana Stepanova, Lena Allweiss, Maura Dandri, Sandra Ciesek, Ulf Dittmer, Walter E. Haefeli, Alexander Alexandrov, Stephan Urban
|
| |
|
|
|
|
|
